Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$39.49 - $44.36 $254,710 - $286,122
-6,450 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$33.17 - $41.6 $24,943 - $31,283
752 Added 13.2%
6,450 $268,000
Q4 2019

Feb 07, 2020

BUY
$25.41 - $43.1 $40,808 - $69,218
1,606 Added 39.25%
5,698 $193,000
Q3 2019

Oct 31, 2019

BUY
$32.73 - $40.81 $12,993 - $16,201
397 Added 10.74%
4,092 $135,000
Q2 2019

Aug 09, 2019

BUY
$35.73 - $41.39 $3,215 - $3,725
90 Added 2.5%
3,695 $150,000
Q1 2019

Apr 24, 2019

BUY
$33.78 - $40.68 $6,283 - $7,566
186 Added 5.44%
3,605 $146,000
Q4 2018

Jan 30, 2019

BUY
$32.65 - $37.95 $111,630 - $129,751
3,419 New
3,419 $118,000
Q4 2017

Feb 07, 2018

SELL
$30.68 - $35.37 $107,993 - $124,502
-3,520 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$31.02 - $32.94 $109,190 - $115,948
3,520
3,520 $111,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.92B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.